LIPTAK ROBERT 4
4 · GLOBUS MEDICAL INC · Filed Aug 10, 2012
Insider Transaction Report
Form 4
LIPTAK ROBERT
Director10% Owner
Transactions
- Sale
Class A Common Stock
2012-08-08$11.16/sh−804,232$8,975,229→ 7,244,201 total(indirect: By L.P.) - Conversion
Class A Common Stock
2012-08-08+7,444,168→ 8,048,433 total(indirect: By L.P.) - Conversion
Series E Preferred Stock
2012-08-08−7,444,168→ 0 total(indirect: By. L.P.)→ Class A Common Stock (7,444,168 underlying)
Footnotes (2)
- [F1]The Company's Series E Preferred Stock automatically converted into the Company's Class A Common Stock on a one-for-one basis upon the closing of the Company's initial public offering and had no expiration date.
- [F2]Clarus Ventures I Management, L.P. ("Clarus I Management") is the sole general partner of Clarus Lifesciences I, L.P. and Clarus Ventures I, LLC ("Clarus I GPLLC") is the sole general partner of Clarus I Management. Mr. Liptak is a managing director of Clarus I GPLLC. As a managing director of Clarus I GPLLC, Mr. Liptak has shared voting and disposition power related to these shares and disclaims beneficial ownership of these shares.